PARIS--(BUSINESS WIRE)--Regulatory News:
Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven pharmaceutical group, today reported its sales for the third quarter and first nine months of 2016.
Commenting on the third quarter 2016 performance, David Meek, Chief Executive Officer of Ipsen said: “We are satisfied with the excellent performance achieved in the third quarter.
Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven pharmaceutical group, today reported its sales for the third quarter and first nine months of 2016.
Commenting on the third quarter 2016 performance, David Meek, Chief Executive Officer of Ipsen said: “We are satisfied with the excellent performance achieved in the third quarter.
